A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease
Authors
Keywords
Parkinson's disease, Inflammasome, NLR family, pyrin domain-containing 3 protein, MCC950, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 354, Issue -, Pages 577543
Publisher
Elsevier BV
Online
2021-03-09
DOI
10.1016/j.jneuroim.2021.577543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of NLRP3 in microglia exacerbates diesel exhaust particles-induced impairment in learning and memory in mice
- (2020) Xiaobo Li et al. ENVIRONMENT INTERNATIONAL
- Therapeutic modulation of inflammasome pathways
- (2020) Dhruv Chauhan et al. IMMUNOLOGICAL REVIEWS
- Microglia Gone Awry: Linking Immunometabolism to Neurodegeneration
- (2020) Ruqayya Afridi et al. Frontiers in Cellular Neuroscience
- MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation
- (2020) Maorong Jiang et al. Journal of Neuroinflammation
- Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
- (2020) Vaidya Govindarajan et al. Journal of Neuroinflammation
- Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease
- (2020) Massimo Filippi et al. MOVEMENT DISORDERS
- Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease
- (2020) Yidan Zhang et al. NEUROCHEMICAL RESEARCH
- Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 mice
- (2020) Jie Li et al. EXPERIMENTAL BRAIN RESEARCH
- Inflammation, Infectious Triggers, and Parkinson's Disease
- (2019) Elisa Caggiu et al. Frontiers in Neurology
- LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
- (2019) Gregor Bieri et al. ACTA NEUROPATHOLOGICA
- Drug treatment strategies for depression in Parkinson disease
- (2019) Melody Ryan et al. EXPERT OPINION ON PHARMACOTHERAPY
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- MCC950 closes the active conformation of NLRP3 to an inactive state
- (2019) Ana Tapia-Abellán et al. Nature Chemical Biology
- Introduction and classical environmental risk factors for Parkinson
- (2019) C. Tranchant REVUE NEUROLOGIQUE
- Hippocampal damage and white matter lesions contribute to cognitive impairment in MPTP-lesioned mice with chronic cerebral hypoperfusion
- (2019) Yuyuan Gao et al. BEHAVIOURAL BRAIN RESEARCH
- MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
- (2018) Eunju Lee et al. CELL DEATH AND DIFFERENTIATION
- Hoehn and Yahr staging of Parkinson rsquo s disease in relation to neuropsychological measures
- (2018) Edward Justin Modestino Frontiers in Bioscience-Landmark
- Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop
- (2018) François Mouton-Liger et al. GLIA
- Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson’s disease
- (2018) Chen Qiao et al. Journal of Neuroinflammation
- MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury
- (2018) Saifudeen Ismael et al. JOURNAL OF NEUROTRAUMA
- Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review
- (2018) Yue Lang et al. MEDIATORS OF INFLAMMATION
- Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury
- (2018) Xin Xu et al. NEUROBIOLOGY OF DISEASE
- OUP accepted manuscript
- (2018) BRAIN
- The inflammasomes, immune guardians at defence barriers
- (2018) Pablo Palazon-Riquelme et al. IMMUNOLOGY
- Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis
- (2018) Ling Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
- (2018) Richard Gordon et al. Science Translational Medicine
- Cognitive changes in prodromal Parkinson's disease: A review
- (2017) Sophie Fengler et al. MOVEMENT DISORDERS
- Microglial phenotypes in Parkinson’s disease and animal models of the disease
- (2017) Valerie Joers et al. PROGRESS IN NEUROBIOLOGY
- Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain
- (2017) Nemat Khan et al. INFLAMMOPHARMACOLOGY
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
- (2015) Yiqing Yan et al. CELL
- Brain region-dependent differential expression of alpha-synuclein
- (2015) Katsutoshi Taguchi et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now